Decubitus ulcer infection and bacteremia due to tazobactam/piperacillin-resistant Veillonella parvula

Shoko Sahara, Teruhisa Kinoshita, Tomomi Amano, Misa Ishida, Takashi Yamakita, Norio Takimoto, Keisuke Oka

Research output: Contribution to journalArticlepeer-review

Abstract

This is the first case report of decubitus infection and bacteremia due to Veillonella parvula (V. parvula). A patient in his 70s with pre-existing diabetes mellitus was admitted with decubitus infection, and tazobactam/piperacillin treatment was initiated. Tazobactam/piperacillin-resistant V. parvula was detected in the blood and decubitus site cultures. The antimicrobial treatment was changed to clindamycin and cefmetazole. Antimicrobial therapy was administered for 28 days. The patient was transferred to a convalescent hospital. V. parvula occasionally causes infection in immunocompromised patients with underlying diseases, such as diabetes. An appropriate evaluation by culture test is important for diagnosis, treatment, and recurrence prevention. Tazobactam/piperacillin is often used in the treatment of multi-bacterial infections such as decubitus infections. V. parvula may be resistant to tazobactam/piperacillin, and this possibility should be taken into account when administering treatment.

Original languageEnglish
Pages (from-to)524-553
Number of pages30
JournalNagoya journal of medical science
Volume86
Issue number3
DOIs
Publication statusPublished - 2024
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • General Medicine

Fingerprint

Dive into the research topics of 'Decubitus ulcer infection and bacteremia due to tazobactam/piperacillin-resistant Veillonella parvula'. Together they form a unique fingerprint.

Cite this